HS006

RHCACD20MA · Zhejiang Hisun Pharmaceutical Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HS006, covering 2018-04-02 to 2018-04-02. Get the full timeline:

Most recent: Clinical Trial Update: RHCACD20MA (HS006) Combined With CHOP (Hi-CHOP) in Patients With Previously Untreated Diffuse Large B-cell Lymphoma [Phase 2]

See pricing